Pai‐Chi Teng

1.1k total citations
15 papers, 506 citations indexed

About

Pai‐Chi Teng is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Pai‐Chi Teng has authored 15 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Pai‐Chi Teng's work include Cancer Genomics and Diagnostics (5 papers), Prostate Cancer Treatment and Research (5 papers) and Cancer Cells and Metastasis (4 papers). Pai‐Chi Teng is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Prostate Cancer Treatment and Research (5 papers) and Cancer Cells and Metastasis (4 papers). Pai‐Chi Teng collaborates with scholars based in United States, Taiwan and Singapore. Pai‐Chi Teng's co-authors include Hsian‐Rong Tseng, Pin‐Jung Chen, Ju Dong Yang, Edwin M. Posadas, Shelly C. Lu, Joseph Ahn, Ting‐Yi Lin, Yazhen Zhu, Yu‐Jer Hsiao and Aliaksandr A. Yarmishyn and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and International Journal of Molecular Sciences.

In The Last Decade

Pai‐Chi Teng

14 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pai‐Chi Teng United States	7	239	215	173	143	89	15	506
Pin‐Jung Chen United States	6	141 0.6×	158 0.7×	166 1.0×	149 1.0×	70 0.8×	19	399
Zu-Shun Chen China	7	112 0.5×	185 0.9×	165 1.0×	128 0.9×	64 0.7×	10	356
Anisha Madhav United States	10	241 1.0×	135 0.6×	187 1.1×	58 0.4×	150 1.7×	12	490
Guannan Tang China	14	407 1.7×	366 1.7×	170 1.0×	80 0.6×	78 0.9×	23	726
Junhao Zheng China	9	292 1.2×	223 1.0×	61 0.4×	118 0.8×	62 0.7×	30	492
Ge Lou China	9	161 0.7×	108 0.5×	145 0.8×	27 0.2×	66 0.7×	23	384
Liye Tao China	9	170 0.7×	124 0.6×	59 0.3×	93 0.7×	55 0.6×	26	353
Jinzhang Chen China	10	90 0.4×	75 0.3×	116 0.7×	143 1.0×	106 1.2×	32	380
Chen-Yu Hu China	12	214 0.9×	126 0.6×	85 0.5×	43 0.3×	41 0.5×	19	371

Countries citing papers authored by Pai‐Chi Teng

Since Specialization

Citations

This map shows the geographic impact of Pai‐Chi Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pai‐Chi Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pai‐Chi Teng more than expected).

Fields of papers citing papers by Pai‐Chi Teng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pai‐Chi Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pai‐Chi Teng. The network helps show where Pai‐Chi Teng may publish in the future.

Co-authorship network of co-authors of Pai‐Chi Teng

This figure shows the co-authorship network connecting the top 25 collaborators of Pai‐Chi Teng. A scholar is included among the top collaborators of Pai‐Chi Teng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pai‐Chi Teng. Pai‐Chi Teng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Wang, Ching‐Yun, et al.. (2024). Updated clinical evidence and molecular features of antibody-drug conjugates for advanced urothelial carcinoma. Urological Science. 35(3). 103–111.

Lee, Meng‐Shiue, Yueh Chien, Pai‐Chi Teng, et al.. (2022). Superrepellent Doubly Reentrant Geometry Promotes Antibiofouling and Prevention of Coronavirus Contamination. Advanced Materials Technologies. 8(1). 2200387–2200387. 4 indexed citations

Teng, Pai‐Chi, Vatche G. Agopian, Ting‐Yi Lin, et al.. (2022). Circulating tumor cells: A step toward precision medicine in hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 37(7). 1179–1190. 9 indexed citations

Teng, Pai‐Chi, Daniel Q. Huang, Ting‐Yi Lin, Mazen Noureddin, & Ju Dong Yang. (2022). Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease. Gut and Liver. 17(1). 24–33. 17 indexed citations

Liu, Chia-Hsin, Shu‐Chi Wang, Shu‐Pin Huang, et al.. (2022). Identification of a Steroid Hormone-Associated Gene Signature Predicting the Prognosis of Prostate Cancer through an Integrative Bioinformatics Analysis. Cancers. 14(6). 1565–1565. 3 indexed citations

Teng, Pai‐Chi, Yanwen Liang, Aliaksandr A. Yarmishyn, et al.. (2021). RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases. International Journal of Molecular Sciences. 22(19). 10592–10592. 100 indexed citations

Hsiao, Yu‐Jer, Pai‐Chi Teng, Tung-Mei Kuang, et al.. (2021). Genome-Wide Polygenic Risk Score for Predicting High Risk Glaucoma Individuals of Han Chinese Ancestry. Journal of Personalized Medicine. 11(11). 1169–1169. 6 indexed citations

Teng, Pai‐Chi, Shu‐Pin Huang, Chia-Hsin Liu, et al.. (2021). Identification of DNA Damage Repair-Associated Prognostic Biomarkers for Prostate Cancer Using Transcriptomic Data Analysis. International Journal of Molecular Sciences. 22(21). 11771–11771. 8 indexed citations

Cavassani, Karen A., Pai‐Chi Teng, Jie‐Fu Chen, et al.. (2021). Nuclear size of circulating tumor cells in advanced prostate cancer to reveal a potential biomarker for clinical outcomes and androgen receptor indifference.. Journal of Clinical Oncology. 39(6_suppl). 167–167. 1 indexed citations

10.

Teng, Pai‐Chi, Yu Jen Jan, Jie‐Fu Chen, et al.. (2020). Prostate cancer CTC-RNA Assay: A new method for contemporary genomics and precision medicine via liquid biopsy.. Journal of Clinical Oncology. 38(6_suppl). 170–170. 1 indexed citations

11.

Winograd, Paul, Shuang Hou, Colin M. Court, et al.. (2020). Hepatocellular Carcinoma–Circulating Tumor Cells Expressing PD‐L1 Are Prognostic and Potentially Associated With Response to Checkpoint Inhibitors. Hepatology Communications. 4(10). 1527–1540. 82 indexed citations

12.

Ahn, Joseph, Pai‐Chi Teng, Pin‐Jung Chen, et al.. (2020). Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma. Hepatology. 73(1). 422–436. 261 indexed citations

13.

Teng, Pai‐Chi, Yu Jen Jan, Minhyung Kim, et al.. (2020). Development of a circulating tumor cell-based RNA classifier for patients with castration-resistant prostate cancer: CTC-PCS/PAM50.. Journal of Clinical Oncology. 38(15_suppl). e17509–e17509. 1 indexed citations

14.

Teng, Pai‐Chi, Yu Jen Jan, Junhee Yoon, et al.. (2019). A circulating tumor cell specific RNA assay for assessment of androgen receptor signaling inhibitor sensitivity in metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. 37(15_suppl). 5059–5059. 1 indexed citations

15.

Chen, Pin‐Jung, Pai‐Chi Teng, Yazhen Zhu, et al.. (2019). Noninvasive Prenatal Diagnostics: Recent Developments Using Circulating Fetal Nucleated Cells. Current Obstetrics and Gynecology Reports. 8(1). 1–8. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact